List of Tables
Table 1. Global Implantable Drug-Eluting Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Implantable Drug-Eluting Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Implantable Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Implantable Drug-Eluting Devices Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Implantable Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Implantable Drug-Eluting Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Implantable Drug-Eluting Devices, Product Type & Application
Table 12. Global Key Manufacturers of Implantable Drug-Eluting Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug-Eluting Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Implantable Drug-Eluting Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Implantable Drug-Eluting Devices Sales by Region (2020-2025) & (Units)
Table 18. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2020-2025)
Table 19. Global Implantable Drug-Eluting Devices Sales by Region (2026-2031) & (Units)
Table 20. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2026-2031)
Table 21. Global Implantable Drug-Eluting Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Implantable Drug-Eluting Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Implantable Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Implantable Drug-Eluting Devices Sales by Country (2020-2025) & (Units)
Table 27. North America Implantable Drug-Eluting Devices Sales by Country (2026-2031) & (Units)
Table 28. North America Implantable Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Implantable Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Implantable Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Implantable Drug-Eluting Devices Sales by Country (2020-2025) & (Units)
Table 32. Europe Implantable Drug-Eluting Devices Sales by Country (2026-2031) & (Units)
Table 33. Europe Implantable Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Implantable Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Implantable Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Implantable Drug-Eluting Devices Sales by Country (2020-2025) & (Units)
Table 42. Latin America Implantable Drug-Eluting Devices Sales by Country (2026-2031) & (Units)
Table 43. Latin America Implantable Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Implantable Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Implantable Drug-Eluting Devices Sales (Units) by Type (2020-2025)
Table 51. Global Implantable Drug-Eluting Devices Sales (Units) by Type (2026-2031)
Table 52. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2020-2025)
Table 53. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2026-2031)
Table 54. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2020-2025)
Table 59. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2026-2031)
Table 60. Global Implantable Drug-Eluting Devices Sales (Units) by Application (2020-2025)
Table 61. Global Implantable Drug-Eluting Devices Sales (Units) by Application (2026-2031)
Table 62. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2020-2025)
Table 63. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2026-2031)
Table 64. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Implantable Drug-Eluting Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2020-2025)
Table 69. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Implantable Drug-Eluting Devices Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Medtronic Implantable Drug-Eluting Devices Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Implantable Drug-Eluting Devices Product
Table 84. Merck Recent Developments/Updates
Table 85. Bayer AG Company Information
Table 86. Bayer AG Description and Business Overview
Table 87. Bayer AG Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer AG Implantable Drug-Eluting Devices Product
Table 89. Bayer AG Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Implantable Drug-Eluting Devices Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Abbott Company Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abbott Implantable Drug-Eluting Devices Product
Table 99. Abbott Recent Developments/Updates
Table 100. Surmodics Company Information
Table 101. Surmodics Description and Business Overview
Table 102. Surmodics Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Surmodics Implantable Drug-Eluting Devices Product
Table 104. Surmodics Recent Developments/Updates
Table 105. Boston Scientific Corporation Company Information
Table 106. Boston Scientific Corporation Description and Business Overview
Table 107. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Boston Scientific Corporation Implantable Drug-Eluting Devices Product
Table 109. Boston Scientific Corporation Recent Developments/Updates
Table 110. Titan Pharmaceuticals, Inc. Company Information
Table 111. Titan Pharmaceuticals, Inc. Description and Business Overview
Table 112. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product
Table 114. Titan Pharmaceuticals, Inc. Recent Developments/Updates
Table 115. BIOTRONIK Company Information
Table 116. BIOTRONIK Description and Business Overview
Table 117. BIOTRONIK Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. BIOTRONIK Implantable Drug-Eluting Devices Product
Table 119. BIOTRONIK Recent Developments/Updates
Table 120. Allergan Company Information
Table 121. Allergan Description and Business Overview
Table 122. Allergan Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Allergan Implantable Drug-Eluting Devices Product
Table 124. Allergan Recent Developments/Updates
Table 125. Bausch & Lomb Company Information
Table 126. Bausch & Lomb Description and Business Overview
Table 127. Bausch & Lomb Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Bausch & Lomb Implantable Drug-Eluting Devices Product
Table 129. Bausch & Lomb Recent Developments/Updates
Table 130. REVA Medical Company Information
Table 131. REVA Medical Description and Business Overview
Table 132. REVA Medical Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. REVA Medical Implantable Drug-Eluting Devices Product
Table 134. REVA Medical Recent Developments/Updates
Table 135. MicroPort Medical Company Information
Table 136. MicroPort Medical Description and Business Overview
Table 137. MicroPort Medical Implantable Drug-Eluting Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. MicroPort Medical Implantable Drug-Eluting Devices Product
Table 139. MicroPort Medical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Implantable Drug-Eluting Devices Distributors List
Table 143. Implantable Drug-Eluting Devices Customers List
Table 144. Implantable Drug-Eluting Devices Market Trends
Table 145. Implantable Drug-Eluting Devices Market Drivers
Table 146. Implantable Drug-Eluting Devices Market Challenges
Table 147. Implantable Drug-Eluting Devices Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Implantable Drug-Eluting Devices
Figure 2. Global Implantable Drug-Eluting Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Implantable Drug-Eluting Devices Market Share by Type: 2024 & 2031
Figure 4. Implantable Drug Infusion Pumps Product Picture
Figure 5. Intraocular Drug-Eluting Devices Product Picture
Figure 6. Contraceptive Drug-Eluting Devices Product Picture
Figure 7. Drug-Eluting Stents Product Picture
Figure 8. Others Product Picture
Figure 9. Global Implantable Drug-Eluting Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Implantable Drug-Eluting Devices Market Share by Application: 2024 & 2031
Figure 11. Diabetes
Figure 12. Contraception
Figure 13. HIV/AIDS Prevention
Figure 14. Chronic Pain Management
Figure 15. Cardiovascular
Figure 16. Ophthalmology
Figure 17. Oncology
Figure 18. Others
Figure 19. Global Implantable Drug-Eluting Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Implantable Drug-Eluting Devices Market Size (2020-2031) & (US$ Million)
Figure 21. Global Implantable Drug-Eluting Devices Sales (2020-2031) & (Units)
Figure 22. Global Implantable Drug-Eluting Devices Average Price (USD/Unit) & (2020-2031)
Figure 23. Implantable Drug-Eluting Devices Report Years Considered
Figure 24. Implantable Drug-Eluting Devices Sales Share by Manufacturers in 2024
Figure 25. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest Implantable Drug-Eluting Devices Players: Market Share by Revenue in Implantable Drug-Eluting Devices in 2024
Figure 27. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global Implantable Drug-Eluting Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 30. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 31. U.S. Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 34. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 35. Germany Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2020-2031)
Figure 42. China Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Taiwan Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Indonesia Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Thailand Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Malaysia Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Philippines Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Latin America Implantable Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 53. Latin America Implantable Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 54. Mexico Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Brazil Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Argentina Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 59. Turkey Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Saudi Arabia Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. U.A.E Implantable Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Global Sales Market Share of Implantable Drug-Eluting Devices by Type (2020-2031)
Figure 63. Global Revenue Market Share of Implantable Drug-Eluting Devices by Type (2020-2031)
Figure 64. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2020-2031)
Figure 65. Global Sales Market Share of Implantable Drug-Eluting Devices by Application (2020-2031)
Figure 66. Global Revenue Market Share of Implantable Drug-Eluting Devices by Application (2020-2031)
Figure 67. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2020-2031)
Figure 68. Implantable Drug-Eluting Devices Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
